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Clostridium difficile was isolated from 12 (20%) of 60
retail ground meat samples purchased over a 10-month
period in 2005 in Canada. Eleven isolates were toxigenic,
and 8 (67%) were classified as toxinotype III. The human
health implications of this finding are unclear, but with the
virulence of toxinotype III strains further studies are
required.
C
lostridium difficile is an important spore-forming
human pathogen associated with serious enteric dis-
eases worldwide (1–3). Recently, the epidemiology of C.
difficile–associated diarrhea (CDAD), appears to have
changed; increased illness and relapse rates have been
reported (1,3). Much of this change has been attributed to
the emergence of 1 toxigenic strain, classified according to
PCR as ribotype 027/toxinotype III and pulsed-field gel
electrophoresis (PFGE) as NAP1 (2).
Toxigenic strains of C. difficile typically produce 2
major toxins, A and B, although a small percentage pro-
duce only toxin B (3). Certain strains may also produce a
binary toxin (known as CDT), whose clinical relevance is
under investigation. PCR ribotype 027 strains produce all
3 toxins and have a mutated toxin regulatory gene, tcdC,
which is thought to be associated with increased toxin
production in vitro (2).
C. difficile is also associated with enteric diseases in
animals, including horses, dogs, and pigs (4,5). Recent
reports indicating that human and animal isolates are often
indistinguishable (4,6) and that PCR ribotype 027 has been
isolated from a dog (7) have created concerns regarding
potential public health implications. C. difficile, including
PCR ribotype 027 (4), has also been isolated from dairy
calves, beef calves, veal calves, and adult cattle in Ontario
(A. Rodriguez-Palacios et al., unpub. data).
The presence of C.  difficile spores in bovine feces
indicates the potential for contamination of retail meat
products. Although contamination does not necessarily
mean foodborne transmission, the possibility of C. difficile
being a foodborne pathogen should be investigated. We
therefore evaluated the prevalence of C. difficile contami-
nation of retail ground meat samples and characterized the
isolates.
The Study
A convenience sampling scheme was used whereby
meat samples (beef, n = 53 and veal, n = 7) were purchased
from 5 grocery retailers in Ontario (4 stores, 57 samples)
and Quebec (1 store, 3 samples), Canada. The number of
meat packages purchased per month was 12, 2, 4, 4, 2, 2, 1,
11, 21, and 1, from January to October 2005, respectively.
C. difficile were isolated by using C. difficile culture
agar supplemented with C. difficile moxalactam nor-
floxacin (CDMN) and 5% horse blood (CM0601,
SR0173E, and SR0048C, Oxoid, Basingstoke, United
Kingdom) (8). C. difficile broth was prepared by mixing
the ingredients of CM0601, except for the agar, with 0.1%
sodium taurocholate (Sigma-Aldrich, Inc., St. Louis, MO,
USA). Briefly, 4–5 g of each sample was added to 20 mL
of prereduced CDMN broth and incubated anaerobically at
37°C for 10–15 days. Alcohol shock for spore selection
was performed by mixing 2 mLhomogenized culture broth
and 96% ethanol (1:1 [v/v]) for 50 min. After centrifuga-
tion (3,800 × g for 10 min), the sediment was streaked onto
C. difficile agar. Up to 2 suspected colonies (swarming,
rough, nonhemolytic) were subcultured from each plate. C.
difficile was presumptively identified on the basis of Gram
stain and detection of L-proline aminopeptidase activity
(Pro Disc, Remel, Lenexa, KS, USA) and confirmed by
identification of the triose phosphate isomerase gene (9). 
PCR ribotyping and gene identification for toxins A
(tcdA) and B (tcdB), the binding component of CDT
(cdtB), and the tcdC gene were performed as previously
described (4,10). Toxinotyping of selected isolates was
also performed (11). Antimicrobial drug susceptibility to
metronidazole, clindamycin, levofloxacin, and van-
comycin was determined for all isolates by using the E-test
method (AB Biodisk, Solna, Sweden) on Mueller-Hinton
agar (12).
C. difficile was isolated from 12 (20%) of 60 meat
samples; 11 (20.8%) of 53 ground beef samples, and 1
(14.3%) of 7 ground veal samples (Table 1). Duplicate
analysis was performed on 4 samples, and isolation of C.
difficile was repeatable.
PCR ribotyping showed distinct patterns (Table 1,
Figure). The most common ribotype, which accounted for
8 (67%) of 12 isolates, was different from any ribotype
previously identified in our laboratory among ≈1,500
human and animal isolates. This ribotype, designated M31,
had genes for toxins A, B and CDT; an 18-bp deletion in
the tcdC gene and was toxinotype III. These are all molec-
ular characteristics of PCR ribotype 027; however, ribo-
type pattern M31 was different from ribotype pattern 027
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*University of Guelph, Guelph, Ontario, Canada(Figure). PFGE with SmaI indicated that although this
strain was distinguishable from prototypic strains NAP1, it
had  ≈80% similarity and was classified as NAP1 (B.
Limbago, pers. comm.).
Two of the remaining 3 ribotypes had classic tcdC
PCR fragments and did not have the cdtB gene. One group
(n = 2), classified as PCR ribotype 077/toxinotype 0, had
been isolated from calves, dogs, and humans (4). Another
isolate from Quebec, classified as PCR ribotype 014/tox-
inotype 0, had also been isolated from calves and humans
(3,4). The fourth isolate, nontoxigenic ribotype M26, had
been isolated from dogs (6) but could not be toxinotyped
because there was no detectable pathogenicity locus (M.
Rupnik, pers. comm.). Overall, 3 (25%) of 12 meat C. dif-
ficile isolates were indistinguishable from Ontario human
isolates.
All meat isolates were susceptible to metronidazole
and vancomycin and resistant to levofloxacin and clin-
damycin (Table 2). These results are in agreement with
previous findings for bovine-derived strains (4)
Conclusions
This is the first study to identify C. difficile spores in
retail ground meat intended for human consumption.
Previously, a study investigating the role of psychrotroph-
ic clostridia on “blown pack” spoilage of commercial
packages of chilled vacuum-packed meats and dog rolls
reported 2 incidental isolates of C. difficile (13). More
recently, a C. difficile isolate was identified in a commer-
cial turkey-based raw diet intended for dogs (14).
The proportion of meat samples contaminated with C.
difficile in our study (20%, 12/60) seems higher than those
in the aforementioned reports. Possible reasons include the
use of a more selective culture protocol in this study (8) and
a potential temporary cluster of isolates with PCR ribotype
M31 (Table 1). Those meat samples may have originated
from the same larger contaminated batch or were subse-
quently contaminated at the store level during repackaging
of retail products. PCR ribotype M31 was not identified in
other samples or stores, which may suggest contamination
at the retail level. Because PCR ribotype M31/toxinotype
III had not been isolated in our laboratory, contamination
during processing is unlikely.
The identification of PCR ribotypes 077 and 014,
which are recognized human pathogens (3,15), is of con-
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Figure. Comparison of PCR ribotypes of Clostridium difficile iso-
lates from meat and of human, bovine, and canine origin in
Ontario, Canada, 2005, by using the method of Bidet et al (10).
PCR 077, 014, and 027 represent international ribotype nomencla-
ture recently reported for calves (4). PCR M26 and M31 are tem-
porary ribotype designations. Note that PCR M31 and 027, both
NAP1/toxinotype III ribotypes, are different.cern, although the actual risk for disease is unclear. Of
additional concern is isolation of toxinotype III strains that
have many similarities with PCR ribotype 027, an impor-
tant cause of CDAD in humans (2). This similarity was
highlighted by classification of this strain by PFGE as
NAP1.
The presence of meat-derived PCR ribotypes indistin-
guishable from human, bovine, and canine ribotypes fur-
ther supports the potential risk for cross-transmission
among species and suggests that ingestion of viable spores
might occur. Although proper cooking of meat is empha-
sized for reducing the risk for foodborne disease, the fact
that C. difficile is a spore former complicates this issue
because spores can survive in ground beef at recommend-
ed cooking temperatures (71°C), even when that tempera-
ture is maintained for 120 min (A. Rodriguez-Palacios et
al., unpub. data).
The clinical and epidemiologic relevance of these
microbiologic findings remains unknown. The isolation of
C. difficile from meat samples does not necessarily mean
that CDAD is a foodborne disease. Additional studies are
required to determine the prevalence of contamination and
its clinical relevance.
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